Advamed said its longtime CEO Steve Ubl will resign from his position effective October 15.
Ubl has spent 16 years with AdvaMed, with the last 10 years of his tenure as president & CEO, raising the medical device industry’s national profile and leading the fight against the medical device tax enacted as part of Obamacare. Ubl lead the group in international expansion, including a recently opened office in China Advamed said.
Ubl was the 6th-highest-paid healthcare lobbyist last year, with total compensation of almost $2 million, according to an analysis by Modern Healthcare.
Advamed said it is undertaking a national search for a replacement for Ubl.
It was reported earlier this week that Ubl would leave to head the pharmaceutical industry’s largest trade group, the Pharmaceutical Research and Manufacturers of America or PhRMA.
PhRMA’s leader, John Castellani, announced plans to step down in April after 10 years as CEO.
The post AdvaMed CEO Ubl steps down appeared first on MassDevice.
from MassDevice http://ift.tt/1LbVI2P
Cap comentari:
Publica un comentari a l'entrada